Cargando…
Adverse Events Following COVID-19 Vaccination in Transfusion-Dependent -Thalassemia Patients
INTRODUCTION: Patients with transfusion-dependent-thalassemia (TDT) are considered as increased risk population for severe and/or morbid COVID-19 infection. Timely vaccination is the main preventive method for severe COVID-19. Different adverse events and reactions following vaccination have been re...
Autores principales: | Delaporta, Polyxeni, Lampropoulou, Eugenia, Moschoviti, Anastasia, Binenbaum, Ilona, Kyriakopoulou, Dimitra, Ioakeimidou, Natalia, Chante, Sofia, Papassotiriou, Ioannis, Kattamis, Antonis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701515/ http://dx.doi.org/10.1182/blood-2021-152118 |
Ejemplares similares
-
Serological Response to BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients with Transfusion Dependent Thalassemia
por: Zucano, Stefania, et al.
Publicado: (2021) -
COVID 19 and Hemoglobinopathies: Update of the Italian Experience
por: Motta, Irene, et al.
Publicado: (2020) -
S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
por: Delaporta, P, et al.
Publicado: (2022) -
Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
por: Kanavaki, Aikaterini, et al.
Publicado: (2017) -
PB2532: VARIABLE HEMATOLOGICAL AND CLINICAL PHENOTYPES IN DOUBLE HETEROZYGOTES OF ΒETA-THALASSEMIA AND TRIPLICATED ΑLPHA-GLOBIN GENES
por: Delaporta, Polyxeni, et al.
Publicado: (2023)